- Home
- TCRX vs IDN Comparison
TCRX vs IDN Comparison
Compare TCRX & IDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TCRX | IDN |
|---|---|---|
| Founded | 2018 | 1994 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 75.1M | 87.5M |
| IPO Year | 2021 | 2014 |
Fundamental Metrics
Financial Performance| Metric | TCRX | IDN |
|---|---|---|
| Price | $0.98 | $4.12 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 3 |
| Target Price | $7.00 | ★ $7.33 |
| AVG Volume (30 Days) | 580.7K | ★ 681.8K |
| Earning Date | 05-08-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 12.28 | ★ 220.00 |
| EPS | N/A | ★ 0.03 |
| Revenue | ★ $10,325,000.00 | $4,433,454.00 |
| Revenue This Year | N/A | $12.54 |
| Revenue Next Year | $19.81 | $15.32 |
| P/E Ratio | ★ N/A | $144.67 |
| Revenue Growth | ★ 266.65 | 23.21 |
| 52 Week Low | $0.88 | $4.00 |
| 52 Week High | $2.57 | $9.08 |
Technical Indicators
Market Signals| Indicator | TCRX | IDN |
|---|---|---|
| Relative Strength Index (RSI) | 40.60 | 30.03 |
| Support Level | $0.91 | $4.01 |
| Resistance Level | $1.16 | $5.07 |
| Average True Range (ATR) | 0.06 | 0.25 |
| MACD | -0.01 | 0.04 |
| Stochastic Oscillator | 21.57 | 21.00 |
Price Performance
Historical ComparisonAbout TCRX TScan Therapeutics Inc.
TScan Therapeutics Inc is a fully integrated clinical-stage biotechnology company focused on developing a robust pipeline of T cell receptor (TCR)-engineered T cell, or TCR-T, therapies for the treatment of patients with cancer. The company's liquid tumor TCR-T therapy candidates, TSC-100 and TSC-101, are in development for the treatment of patients with hematologic malignancies to eliminate residual leukemia and prevent relapse after hematopoietic stem cell transplantation. It is also developing multiplexed TCR-T therapy candidates for the treatment of various solid tumors.
About IDN Intellicheck Inc.
Intellicheck Inc is a trusted industry leader in technology solutions that stop identity theft and fraud with real-time identification authentication and age verification. The group delivers on-demand digital and physical identity verification solutions for KYC, AML, fraud prevention, and age verification needs. The products of the company includes solutions for preventing identity fraud across any industry delivered via smartphone, tablet, POS integration or other electronic devices.